The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
nabiximols
An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Nabiximols contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | cannabidiol mixture with tetrahydrocannabinol cannabis-based oromucosal spray GW-1000-02 THC and CBD mixture | |
| |||
| US brand name: | | Sativex | |
| |||
| Foreign brand name: | | Sativex | |
| |||
| Code names: | | GW-1000 GW-1000-02 | |
| |||
